Type Public Products Pharmaceuticals, Revenue 16.4 billion INR Net income 1.05 billion INR | Industry Pharmaceuticals Website www.neclife.com Founded 1995 Number of employees 2,200 | |
 | ||
Traded as BSE: 532649NSE: NECLIFE Stock price NECLIFE (NSE) ₹ 35.45 -0.05 (-0.14%)23 Mar, 2:25 PM IST - Disclaimer Subsidiaries Chempharma Private Ltd., Narbada Industries, Nectar Lifesciences US, LLC | ||
Mahesh holikatti nectar lifesciences pharmexcil 2016 hybiz
Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic products for EU and USA. The company is the largest GMP manufacturer of oral and sterile cephalosporins in the world. Its facilities are approved by USFDA, the European Union and Japan.
Contents
Nectar lifesciences ltd factory fire
History
The company is promoted by Mr Sanjiv Goyal and was incorporated in June 1995. The company went public in July 2005 with simultaneous listings on Bombay Stock Exchange and the National Stock Exchange of India. In 2010 New Silk Route Private Equity invested INR 2.5 billion in the company.
Management
Board of Directors:
Market Cap
The current market capitalization is about INR 806.22 cr.
Products
Nectar Lifesciences manufactures oral and sterile active pharmaceutical ingredients, finished dosages and phytochemicals. Nectar is the world's largest manufacturer and exporter of natural menthol and allied products. The company is also in business of providing leading pharmaceutical organizations with contract research and manufacturing services. It also manufactures empty hard gelatin capsules.